Perrigo Company plc Dividends Paid
Perrigo Company plc (PRGO) reported Dividends Paid of $80.10 million for the 6-month period ending 2026-06-27, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfDividends · last filed 2026-08-05
- Perrigo Company plc payments of dividends for the quarter ending 2026-06-27 was $40.20M, a 3.34% increase year-over-year.
- Perrigo Company plc payments of dividends for the quarter ending 2026-03-28 was $39.90M, a 1.72% decline year-over-year.
- Perrigo Company plc payments of dividends for the quarter ending 2025-12-31 was $39.90M, a 0.76% increase year-over-year.
- Perrigo Company plc payments of dividends for the quarter ending 2025-09-27 was $39.90M, a 6.12% increase year-over-year.
- Perrigo Company plc payments of dividends for fiscal 2025 was $159.30M, a 4.46% increase from fiscal 2024.
- Perrigo Company plc payments of dividends for fiscal 2024 was $152.50M, a 1.87% increase from fiscal 2023.
- Perrigo Company plc payments of dividends for fiscal 2023 was $149.70M, a 5.13% increase from fiscal 2022.
- Perrigo Company plc payments of dividends for fiscal 2022 was $142.40M, a 9.88% increase from fiscal 2021.
| Period end | Payments of Dividends 3 month | Payments of Dividends 6 month | Payments of Dividends 9 month | Payments of Dividends 12 month |
|---|---|---|---|---|
| 2026-06-27 | $40.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $80.10M 10-Q · filed 2026-08-05 | $120.00M derived: sum of 3 quarters · filed 2026-08-05 | $159.90M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-28 | $39.90M 10-Q · filed 2026-05-06 | $79.80M derived: sum of 2 quarters · filed 2026-05-06 | $119.70M derived: sum of 3 quarters · filed 2026-05-06 | $158.60M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $39.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $79.80M derived: sum of 2 quarters · filed 2026-02-26 | $118.70M derived: sum of 3 quarters · filed 2026-08-05 | $159.30M 10-K · filed 2026-02-26 |
| 2025-09-27 | $39.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $78.80M derived: sum of 2 quarters · filed 2026-08-05 | $119.40M 10-Q · filed 2025-11-05 | $159.00M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-28 | $38.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $79.50M 10-Q · filed 2026-08-05 | $119.10M derived: sum of 3 quarters · filed 2026-08-05 | $156.70M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-29 | $40.60M 10-Q · filed 2026-05-06 | $80.20M derived: sum of 2 quarters · filed 2026-05-06 | $117.80M derived: sum of 3 quarters · filed 2026-05-06 | $155.50M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $39.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $77.20M derived: sum of 2 quarters · filed 2026-02-26 | $114.90M derived: sum of 3 quarters · filed 2026-02-26 | $152.50M 10-K · filed 2026-02-26 |
| 2024-09-28 | $37.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $75.30M derived: sum of 2 quarters · filed 2025-11-05 | $112.90M 10-Q · filed 2025-11-05 | $150.50M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-29 | $37.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $75.30M 10-Q · filed 2025-08-06 | $112.90M derived: sum of 3 quarters · filed 2026-02-26 | $151.80M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-30 | $37.60M 10-Q · filed 2025-05-07 | $75.20M derived: sum of 2 quarters · filed 2026-02-26 | $114.10M derived: sum of 3 quarters · filed 2026-02-26 | $151.10M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $37.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $76.50M derived: sum of 2 quarters · filed 2026-02-26 | $113.50M derived: sum of 3 quarters · filed 2026-02-26 | $149.70M 10-K · filed 2026-02-26 |
| 2023-09-30 | $38.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $75.90M derived: sum of 2 quarters · filed 2024-11-06 | $112.10M 10-Q · filed 2024-11-06 | $147.50M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-07-01 | $37.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | $73.20M 10-Q · filed 2024-08-02 | $108.60M derived: sum of 3 quarters · filed 2025-02-28 | $146.00M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-04-01 | $36.20M 10-Q · filed 2024-05-07 | $71.60M derived: sum of 2 quarters · filed 2025-02-28 | $109.00M derived: sum of 3 quarters · filed 2025-02-28 | $144.40M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $35.40M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $72.80M derived: sum of 2 quarters · filed 2025-02-28 | $108.20M derived: sum of 3 quarters · filed 2025-02-28 | $142.40M 10-K · filed 2025-02-28 |
| 2022-10-01 | $37.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $72.80M derived: sum of 2 quarters · filed 2023-11-07 | $107.00M 10-Q · filed 2023-11-07 | $138.80M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-07-02 | $35.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $69.60M 10-Q · filed 2023-08-08 | $101.40M derived: sum of 3 quarters · filed 2024-02-27 | $134.10M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-04-02 | $34.20M 10-Q · filed 2023-05-09 | $66.00M derived: sum of 2 quarters · filed 2024-02-27 | $98.70M derived: sum of 3 quarters · filed 2024-02-27 | $131.20M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $31.80M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $64.50M derived: sum of 2 quarters · filed 2024-02-27 | $97.00M derived: sum of 3 quarters · filed 2024-02-27 | $129.60M 10-K · filed 2024-02-27 |
| 2021-10-02 | $32.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $65.20M derived: sum of 2 quarters · filed 2022-11-08 | $97.80M 10-Q · filed 2022-11-08 | $128.70M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-07-03 | $32.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $65.10M 10-Q · filed 2022-08-09 | $96.00M derived: sum of 3 quarters · filed 2023-02-28 | $127.10M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-04-03 | $32.60M 10-Q · filed 2022-05-11 | $63.50M derived: sum of 2 quarters · filed 2023-02-28 | $94.60M derived: sum of 3 quarters · filed 2023-02-28 | $125.60M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $30.90M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $62.00M derived: sum of 2 quarters · filed 2023-02-28 | $93.00M derived: sum of 3 quarters · filed 2023-02-28 | $123.90M 10-K · filed 2023-02-28 |
| 2020-09-26 | $31.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $62.10M derived: sum of 2 quarters · filed 2021-11-12 | $93.00M 10-Q · filed 2021-11-12 | $121.80M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-27 | $31.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $61.90M 10-Q · filed 2021-08-11 | $90.70M derived: sum of 3 quarters · filed 2022-03-01 | $119.50M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-28 | $30.90M 10-Q · filed 2021-05-12 | $59.70M derived: sum of 2 quarters · filed 2022-03-01 | $88.50M derived: sum of 3 quarters · filed 2022-03-01 | $117.40M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $28.80M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $57.60M derived: sum of 2 quarters · filed 2022-03-01 | $86.50M derived: sum of 3 quarters · filed 2022-03-01 | $112.40M 10-K · filed 2022-03-01 |
| 2019-09-28 | $28.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $57.70M derived: sum of 2 quarters · filed 2020-11-05 | $83.60M 10-Q · filed 2020-11-05 | $109.80M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-29 | $28.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $54.80M 10-Q · filed 2020-08-05 | $81.00M derived: sum of 3 quarters · filed 2021-03-01 | $106.90M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-30 | $25.90M 10-Q · filed 2020-05-05 | $52.10M derived: sum of 2 quarters · filed 2021-03-01 | $78.00M derived: sum of 3 quarters · filed 2021-03-01 | $104.10M derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | $26.20M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $52.10M derived: sum of 2 quarters · filed 2021-03-01 | $78.20M derived: sum of 3 quarters · filed 2021-03-01 | $104.90M 10-K · filed 2021-03-01 |
| 2018-09-29 | $25.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $52.00M derived: sum of 2 quarters · filed 2019-11-06 | $78.70M 10-Q · filed 2019-11-06 | $101.10M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-06-30 | $26.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $52.80M 10-Q · filed 2019-08-08 | $75.20M derived: sum of 3 quarters · filed 2020-02-27 | $97.90M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-03-31 | $26.70M 10-Q · filed 2019-05-09 | $49.10M derived: sum of 2 quarters · filed 2020-02-27 | $71.80M derived: sum of 3 quarters · filed 2020-02-27 | $94.80M derived: sum of 4 quarters · filed 2020-02-27 |
| 2017-12-31 | $22.40M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $45.10M derived: sum of 2 quarters · filed 2020-02-27 | $68.10M derived: sum of 3 quarters · filed 2020-02-27 | $91.10M 10-K · filed 2020-02-27 |
| 2017-09-30 | $22.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $45.70M derived: sum of 2 quarters · filed 2018-11-08 | $68.70M 10-Q · filed 2018-11-08 | $89.50M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-07-01 | $23.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $46.00M 10-Q · filed 2018-08-09 | $66.80M derived: sum of 3 quarters · filed 2019-02-27 | $87.60M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-04-01 | $23.00M 10-Q · filed 2018-05-08 | $43.80M derived: sum of 2 quarters · filed 2019-02-27 | $64.60M derived: sum of 3 quarters · filed 2019-02-27 | $85.40M derived: sum of 4 quarters · filed 2019-02-27 |
| 2016-12-31 | $20.80M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $41.60M derived: sum of 2 quarters · filed 2019-02-27 | $62.40M derived: sum of 3 quarters · filed 2019-02-27 | $83.20M 10-K · filed 2019-02-27 |
| 2016-10-01 | $20.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $41.60M derived: sum of 2 quarters · filed 2017-11-09 | $62.40M 10-Q · filed 2017-11-09 | $80.40M derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-07-02 | $20.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | $41.60M 10-Q · filed 2017-08-10 | $59.60M derived: sum of 3 quarters · filed 2018-03-01 | $77.90M derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-04-02 | $20.80M 10-Q · filed 2017-05-30 | $38.80M derived: sum of 2 quarters · filed 2018-03-01 | $57.10M derived: sum of 3 quarters · filed 2018-03-01 | $75.40M derived: sum of 4 quarters · filed 2018-03-01 |
| 2015-12-31 | $18.00M derived: 10-K 6 month − 10-Q 3 month · filed 2018-03-01 | $36.30M 10-K · filed 2018-03-01 | $54.60M derived: sum of 3 quarters · filed 2018-03-01 | $72.20M derived: sum of 4 quarters · filed 2018-03-01 |
| 2015-09-26 | $18.30M 10-Q · filed 2015-11-02 | $36.60M derived: sum of 2 quarters · filed 2017-05-22 | $54.20M 10-Q/A · filed 2017-05-23 | $69.10M derived: sum of 4 quarters · filed 2017-05-22 |
| 2015-06-27 | $18.30M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2017-05-22 | $35.90M 10-Q/A · filed 2017-05-22 | $50.80M derived: sum of 3 quarters · filed 2017-05-22 | $64.80M 10-K · filed 2018-03-01 |
| 2015-03-28 | $17.60M 10-Q/A · filed 2017-05-22 | $32.50M derived: sum of 2 quarters · filed 2017-05-22 | $46.50M 10-Q · filed 2015-04-29 | $60.70M derived: sum of 4 quarters · filed 2017-05-22 |
| 2014-12-27 | $14.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-05 | $29.00M 10-Q · filed 2015-02-05 | $43.10M derived: sum of 3 quarters · filed 2017-05-22 | $57.10M derived: sum of 4 quarters · filed 2017-05-22 |
| 2014-09-27 | $14.10M 10-Q · filed 2015-11-02 | $28.20M derived: sum of 2 quarters · filed 2017-05-22 | $42.20M derived: sum of 3 quarters · filed 2017-05-22 | $51.70M derived: sum of 4 quarters · filed 2017-05-22 |
| 2014-06-28 | $14.10M derived: 10-K 12 month − 10-Q 9 month · filed 2017-05-22 | $28.10M derived: sum of 2 quarters · filed 2017-05-22 | $37.60M derived: sum of 3 quarters · filed 2017-05-22 | $46.10M 10-K · filed 2017-05-22 |
| 2014-03-29 | $14.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-04-29 | $23.50M derived: sum of 2 quarters · filed 2015-04-29 | $32.00M 10-Q · filed 2015-04-29 | $40.50M derived: sum of 4 quarters · filed 2016-02-25 |
| 2013-12-28 | $9.50M derived: 10-Q 6 month − 8-K 3 month · filed 2015-02-05 | $18.00M 10-Q · filed 2015-02-05 | $26.50M derived: sum of 3 quarters · filed 2016-02-25 | $35.00M derived: sum of 4 quarters · filed 2016-02-25 |
| 2013-09-28 | $8.50M 8-K · filed 2014-11-20 | $17.00M derived: sum of 2 quarters · filed 2016-02-25 | $25.50M derived: sum of 3 quarters · filed 2016-02-25 | |
| 2013-06-29 | $8.50M derived: 10-KT 12 month − 10-Q 9 month · filed 2016-02-25 | $17.00M derived: sum of 2 quarters · filed 2016-02-25 | $33.00M 10-KT · filed 2016-02-25 | |
| 2013-03-30 | $8.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-07 | $24.50M 10-Q · filed 2014-05-07 | ||
| 2012-12-29 | $16.00M 10-Q · filed 2014-02-06 | |||
| 2012-06-30 | $29.00M 10-K · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |